Using large-scale GWAS data, researchers saw shared genetic contributors for ALS and frontotemporal dementia, as well as ALS and progressive supranuclear palsy.
The collaborators aim to show that Cytox' VariaTect SNP profiling array and an associated algorithm can effectively predict the presence of Alzheimer's pathology.
Funded projects will will take advantage of molecular platforms that enable large-scale, robust, and reproducible analysis of transcriptional, epigenomic, proteomic, and metabolomic states.
A Japanese research team has found a blood test that might be able to determine whether someone has early-stage Alzheimer's disease, Scientific American reports.
A study published in Nature this week is the latest to suggest that blood-based protein markers could be indicative of amyloid deposit levels in the brain.
Two studies appearing in JAMA Neurology respectively examined how variants linked to Alzheimer's disease and Parkinson's disease contribute to the conditions.
The partners will integrate genomic, imaging, and other data to identify new therapies and personalize treatments for patients with neurological and neurodegenerative diseases.
An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
